Form 4 for RKDA Arcadia Biosciences, Inc.

Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0000950170-25-014814 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2025-02-05	2025-02-03	RKDA	Kawakami Mark	CFO	P - Purchase	$2.49	+700	2,681	+35%	+$1,743

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-02-03	P	A	700	$2.49	2,681	D	—	—	(F1) Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan ("ESPP"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock. (F2) The amount includes the 2015 Employee Stock Purchase Plan ("ESPP") purchases, for the purchase periods from August 1, 2022 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower.